A

Abeona Therapeutics

D

ABEO

USD

0.36

(6.6055%)

Market Closed

20,568.00

حجم التداول

-1.75

الربح لكل سهم

-

العائد الربحي

-3.282486

P/E

251,656,646.57

حجم السوق

اليوم

6.6055%

1 اسبوع

4.122%

1 شهر

10.667%

6 اشهر

-23.250%

12 اشهر

52.094%

بداية السنة

15.968%

كل الوقت

0%

أصول ذات صلة

Title:
Abeona Therapeutics

Sector:

Healthcare

Industry:

Biotechnology

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا